Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04984265
PHASE1/PHASE2

SBRT in Chagas Disease Ventricular Tachycardia

Sponsor: University of Sao Paulo General Hospital

View on ClinicalTrials.gov

Summary

This is an observational study of 10 Chagas Disease patients with Ventricular Tachycardia that have failed prior catheter ablation or have this procedure contraindicated due to clinical status. Those patients will underwent to Stereotactic Body Radiation Therapy (SBRT) targeting the area of the heart of the VT circuits. Radioablation target will be defined based on prior ablation electroanatomical mapping, VT morphology, pre-acquired imaging (CT angiogram, Cardiac Magnetic Resonance), current imaging reconstructed and integrated to electroanatomical mapping and a EP study to define current VT morphologies. Gross targeted volume (GTV), internal targeted volume (ITV) and planning targeted volume (PTV) will be defined and calculated and a single 25Gy dose will be delivered to the PTV. Patients will be followed initially for one year and efficacy endpoint will be rate of VT recurrence, time to recurrence and VT burden. Safety endpoint will be the occurrence of any adverse effect related to SBRT.

Official title: Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia in Chagas Disease Patients

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2021-07-14

Completion Date

2024-07-31

Last Updated

2024-07-16

Healthy Volunteers

No

Interventions

RADIATION

Stereotactic Body Radiation Therapy

SBRT targeting the area of the circuit of Ventricular Tachycardia

Locations (1)

University of Sao Paulo General Hospital

São Paulo, São Paulo, Brazil